Sleep Medicine
-
Specialists review sex-specific variables affecting women with OSA
Ashesha Mechineni, MD, explained some of the embedded subtleties in OSA presentation and diagnostic parameters among women.
-
Case-based discussion to troubleshoot PAP nonadherence in OSA
Ritwick Agrawal, MD, MS, FCCP, will chair a Wednesday afternoon session addressing high nonadherence in PAP therapy for patients with OSA and exploring innovative neurotherapy options to help optimize care for complex cases.
-
Viloxazine-trazodone combo shows promise for OSA relief
Investigator Ludovico Messineo, MD, PhD, said lower dosages will need to be tested to ensure that the beneficial effects on OSA severity are maintained while minimizing side effects.
-
Waking up to simulation in sleep medicine
Simulation-based mastery learning is expanding into sleep medicine training with innovative courses and workshops geared toward honing clinical skills in a controlled environment.
-
Presenters to share insights into new ventilation reimbursement criteria
Peter Gay, MD, FCCP, will chair a session about the implications of revised coverage guidelines for noninvasive positive pressure ventilation devices for patients with COPD.
-
CHEST Community Connections: Get to know Chicago health care heroes
CHEST is partnering with three Chicago-area organizations—Chicago Asthma Consortium, CommunityHealth, and Mobile Care Chicago—to highlight their critical work in the community and connect them with CHEST 2025 attendees.
-
Using consumer sleep trackers in clinical practice
Consumer sleep technologies are offering new ways to monitor sleep. Clinicians need to be prepared to discuss this data, clarify limitations, and interpret findings with patients.
-
Moderate to severe OSA increases risk of severe COVID-19
According to critical care specialist Lina Miyakawa, MD, FCCP, the findings are a reminder that OSA “is not just a sleep disorder but a systemic condition with meaningful public health implications.”
-
Explore recent developments in the treatment of sleep disorders
Multiple sessions will focus extensively on the benefits of glucagon-like peptide-1 (GLP-1) agonists in sleep medicine, said Chitra Lal, MD, MBBS, FCCP, Chair of the Sleep Medicine Curriculum Group and Sleep Medicine Network.
-
Coping styles linked to cognitive complaints in OSA
Investigator Tim J.A. Vaessen, MSc, said the findings suggest clinicians should look beyond sleep apnea and mood symptoms when evaluating cognitive complaints.
-
Practical applications of the new CMS national coverage determination guidelines for noninvasive ventilation in COPD
Many durable medical equipment companies have already started applying the new NIPPV criteria, so it is important for clinicians to become familiar with the changes.
-
Oral medications for sleep in nonintubated ICU patients and their impact on delirium
Clinicians rank pharmacologic sleep aids for ICU patients who are not intubated, beginning with those that have the strongest evidence for safety and efficacy.
